Brief: Xbrane Biopharma Signs Distribution Agreement In South Korea

Xbrane Biopharma AB

19/12/2017 12:45

Dec 19 (Reuters) - Xbrane Biopharma Ab  XBRANE.ST : 
    * REG-XBRANE BIOPHARMA SIGNS AGREEMENT WITH BL&H FOR SALES 
AND 
MARKETING OF SPHEROTIDE IN SOUTH KOREA 
    * WILL RECEIVE MID-SINGLE DIGIT SEK MLN LICENSE FEE FOR 
EXCLUSIVE 
RIGHTS TO SPHEROTIDE IN SOUTH KOREA 
    * XBRANE AND BL&H WILL SHARE PROFITS FROM SALES 
    * TIMING OF LAUNCH IS EXPECTED TO EARLIEST 2019. 
 
Source text for Eikon:  ID:nGNE6CYFRl  
Further company coverage:  XBRANE.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))